AI
IBB icon

Arrien Investments’s iShares Biotechnology ETF IBB Stock Holding History

Arrien Investments’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,458
Closed -$337K – 39
2024
Q2 		$337K Sell
2,458
-5,158
-68% -$689K 0.26% 27
2024
Q1 		$1.05M Buy
+7,616
New +$1.04M 0.83% 18

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Arrien Investments's IBB Position: Q3 2024 in Review

Arrien Investments sold out of iShares Biotechnology ETF (IBB) in Q3 2024, closing a stake of 2,458 shares — an estimated $337K sold.

Arrien Investments first reported a position in IBB in Q1 2024 and held it in 2 quarters. The position peaked at $1.05M in Q1 2024. 893 funds tracked by Wall St. Rank hold IBB as of Q3 2024.

  • Arrien Investments reported no remaining iShares Biotechnology ETF position as of Q3 2024 after selling out during the quarter.
  • Arrien Investments sold 2,458 iShares Biotechnology ETF shares in Q3 2024, an estimated $337K.
  • Arrien Investments first reported a position in iShares Biotechnology ETF in Q1 2024 and held it in 2 quarters.
  • Arrien Investments's iShares Biotechnology ETF position peaked at $1.05M in Q1 2024.
  • 893 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.

Based on Arrien Investments's 13F filing for Q3 2024, filed 10 Apr 2025.